Chronic tonsillitis is a persistent inflammatory condition of the tonsils. Timely, structured management — particularly in the early symptomatic phase — is central to an evidence-based approach.
Symptom relief is the primary focus in the early days after onset. The evidence-based protocol specifies a targeted class of agent appropriate for this phase — but the complete guidance on selection and conditions for use is in the full regimen.
DOI: 10.1007/s00405-015-3872-6
For mere symptom relief, especially within the first 3 days after disease onset, for example acetaminophen (Paracetamol), non-steroidal anti-inflammatory drugs like ibuprofen can be applied with satisfactory results.